US Stock MarketDetailed Quotes

SEEL Seelos Therapeutics

Watchlist
  • 0.1990
  • +0.0095+5.01%
Close Sep 13 16:00 ET
  • 0.1956
  • -0.0034-1.71%
Post 20:02 ET
1.39MMarket Cap0.01P/E (TTM)

Seelos Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-71.34%3.14M
-32.21%6.06M
-42.89%40.5M
-56.12%8.01M
-27.61%12.6M
-48.43%10.95M
-36.25%8.93M
14.99%70.92M
-33.31%18.26M
59.58%17.41M
Selling and administrative expenses
-8.31%2.55M
-23.65%3.11M
2.35%12.59M
-0.22%2.75M
12.29%2.99M
-3.57%2.78M
1.77%4.07M
-18.14%12.3M
-64.84%2.75M
19.44%2.66M
-General and administrative expense
-8.31%2.55M
-23.65%3.11M
2.35%12.59M
-0.22%2.75M
12.29%2.99M
-3.57%2.78M
1.77%4.07M
-18.14%12.3M
-64.84%2.75M
19.44%2.66M
Research and development costs
-88.65%966K
-37.81%3.53M
-48.62%30.12M
-61.83%5.92M
-32.05%10.02M
-53.64%8.51M
-43.37%5.67M
25.66%58.62M
-20.67%15.51M
69.87%14.75M
Other operating expenses
-11.90%-376K
28.34%-579K
---2.2M
---653K
---406K
---336K
---808K
----
----
----
Operating profit
71.34%-3.14M
32.21%-6.06M
42.89%-40.5M
56.12%-8.01M
27.61%-12.6M
48.43%-10.95M
36.25%-8.93M
-14.99%-70.92M
33.31%-18.26M
-59.58%-17.41M
Net non-operating interest income expense
-130.26%-23K
-121.67%-13K
14.95%123K
-117.50%-7K
-117.65%-6K
442.86%76K
215.79%60K
107.21%107K
90.48%40K
78.95%34K
Non-operating interest income
--0
-85.07%10K
63.64%198K
-70.00%12K
0.00%36K
336.84%83K
157.69%67K
7.08%121K
53.85%40K
-7.69%36K
Non-operating interest expense
228.57%23K
228.57%23K
435.71%75K
--19K
2,000.00%42K
40.00%7K
0.00%7K
-99.12%14K
--0
-90.00%2K
Other net income (expense)
126.17%4.87M
174.67%3.4M
191.52%2.49M
682.95%2.57M
1,137.12%23.11M
-39,514.89%-18.62M
-45,490.00%-4.56M
5.84%-2.73M
-568.09%-440K
-3,031.58%-2.23M
Gain on sale of security
137.16%4.87M
207.72%4.9M
527.34%11.65M
682.95%2.57M
1,300.09%26.74M
-27,797.87%-13.11M
-45,360.00%-4.55M
-315.40%-2.73M
-568.09%-440K
-3,031.58%-2.23M
Special income (charges)
--0
-11,384.62%-1.49M
---9.15M
--0
---3.63M
---5.51M
---13K
--0
--0
--0
-Less:Other special charges
----
11,384.62%1.49M
--9.15M
--0
--3.63M
--5.51M
--13K
----
----
----
Income before tax
105.80%1.71M
80.17%-2.66M
48.48%-37.88M
70.77%-5.45M
153.55%10.5M
-38.66%-29.5M
4.07%-13.43M
-11.33%-73.53M
31.56%-18.66M
-81.27%-19.6M
Income tax
Net income
105.80%1.71M
80.17%-2.66M
48.48%-37.88M
70.77%-5.45M
153.55%10.5M
-38.66%-29.5M
4.07%-13.43M
-11.33%-73.53M
31.56%-18.66M
-81.27%-19.6M
Net income continuous Operations
105.80%1.71M
80.17%-2.66M
48.48%-37.88M
70.77%-5.45M
153.55%10.5M
-38.66%-29.5M
4.07%-13.43M
-11.33%-73.53M
31.56%-18.66M
-81.27%-19.6M
Minority interest income
Net income attributable to the parent company
105.80%1.71M
80.17%-2.66M
48.48%-37.88M
70.77%-5.45M
153.55%10.5M
-38.66%-29.5M
4.07%-13.43M
-11.33%-73.53M
31.56%-18.66M
-81.27%-19.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
105.80%1.71M
80.17%-2.66M
48.48%-37.88M
70.77%-5.45M
153.55%10.5M
-38.66%-29.5M
4.07%-13.43M
-11.33%-73.53M
31.56%-18.66M
-81.27%-19.6M
Basic earnings per share
101.27%0.68
94.41%-1.6
62.73%-61.84
101.36%0.56
144.44%19.2
-11.79%-53.66
8.21%-28.64
5.30%-165.92
38.81%-41.12
-63.64%-43.2
Diluted earnings per share
100.22%0.12
94.41%-1.6
62.73%-61.84
101.36%0.56
33.33%-28.8
-11.79%-53.66
8.21%-28.64
5.30%-165.92
38.81%-41.12
-63.64%-43.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -71.34%3.14M-32.21%6.06M-42.89%40.5M-56.12%8.01M-27.61%12.6M-48.43%10.95M-36.25%8.93M14.99%70.92M-33.31%18.26M59.58%17.41M
Selling and administrative expenses -8.31%2.55M-23.65%3.11M2.35%12.59M-0.22%2.75M12.29%2.99M-3.57%2.78M1.77%4.07M-18.14%12.3M-64.84%2.75M19.44%2.66M
-General and administrative expense -8.31%2.55M-23.65%3.11M2.35%12.59M-0.22%2.75M12.29%2.99M-3.57%2.78M1.77%4.07M-18.14%12.3M-64.84%2.75M19.44%2.66M
Research and development costs -88.65%966K-37.81%3.53M-48.62%30.12M-61.83%5.92M-32.05%10.02M-53.64%8.51M-43.37%5.67M25.66%58.62M-20.67%15.51M69.87%14.75M
Other operating expenses -11.90%-376K28.34%-579K---2.2M---653K---406K---336K---808K------------
Operating profit 71.34%-3.14M32.21%-6.06M42.89%-40.5M56.12%-8.01M27.61%-12.6M48.43%-10.95M36.25%-8.93M-14.99%-70.92M33.31%-18.26M-59.58%-17.41M
Net non-operating interest income expense -130.26%-23K-121.67%-13K14.95%123K-117.50%-7K-117.65%-6K442.86%76K215.79%60K107.21%107K90.48%40K78.95%34K
Non-operating interest income --0-85.07%10K63.64%198K-70.00%12K0.00%36K336.84%83K157.69%67K7.08%121K53.85%40K-7.69%36K
Non-operating interest expense 228.57%23K228.57%23K435.71%75K--19K2,000.00%42K40.00%7K0.00%7K-99.12%14K--0-90.00%2K
Other net income (expense) 126.17%4.87M174.67%3.4M191.52%2.49M682.95%2.57M1,137.12%23.11M-39,514.89%-18.62M-45,490.00%-4.56M5.84%-2.73M-568.09%-440K-3,031.58%-2.23M
Gain on sale of security 137.16%4.87M207.72%4.9M527.34%11.65M682.95%2.57M1,300.09%26.74M-27,797.87%-13.11M-45,360.00%-4.55M-315.40%-2.73M-568.09%-440K-3,031.58%-2.23M
Special income (charges) --0-11,384.62%-1.49M---9.15M--0---3.63M---5.51M---13K--0--0--0
-Less:Other special charges ----11,384.62%1.49M--9.15M--0--3.63M--5.51M--13K------------
Income before tax 105.80%1.71M80.17%-2.66M48.48%-37.88M70.77%-5.45M153.55%10.5M-38.66%-29.5M4.07%-13.43M-11.33%-73.53M31.56%-18.66M-81.27%-19.6M
Income tax
Net income 105.80%1.71M80.17%-2.66M48.48%-37.88M70.77%-5.45M153.55%10.5M-38.66%-29.5M4.07%-13.43M-11.33%-73.53M31.56%-18.66M-81.27%-19.6M
Net income continuous Operations 105.80%1.71M80.17%-2.66M48.48%-37.88M70.77%-5.45M153.55%10.5M-38.66%-29.5M4.07%-13.43M-11.33%-73.53M31.56%-18.66M-81.27%-19.6M
Minority interest income
Net income attributable to the parent company 105.80%1.71M80.17%-2.66M48.48%-37.88M70.77%-5.45M153.55%10.5M-38.66%-29.5M4.07%-13.43M-11.33%-73.53M31.56%-18.66M-81.27%-19.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 105.80%1.71M80.17%-2.66M48.48%-37.88M70.77%-5.45M153.55%10.5M-38.66%-29.5M4.07%-13.43M-11.33%-73.53M31.56%-18.66M-81.27%-19.6M
Basic earnings per share 101.27%0.6894.41%-1.662.73%-61.84101.36%0.56144.44%19.2-11.79%-53.668.21%-28.645.30%-165.9238.81%-41.12-63.64%-43.2
Diluted earnings per share 100.22%0.1294.41%-1.662.73%-61.84101.36%0.5633.33%-28.8-11.79%-53.668.21%-28.645.30%-165.9238.81%-41.12-63.64%-43.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data